Founded in 2012 and based in central Cambridge, Cambridge Nutraceuticals focuses on developing bioavailable supplements with clinically proven benefits. Initially launching with "Ateronon," a patented form of bioavailable lycopene, the company expanded its product line in December 2015 under the brand FutureYou. Their mission is to enhance health through scientifically-backed supplements, leveraging close ties with Cambridge University to ensure rigorous research and development.
Cambridge Nutraceuticals boasts a high-profile medical board that supports its scientific endeavors. Notable achievements include the successful market introduction of multiple clinically-proven supplements and significant growth since its inception. The company's impact lies in its commitment to evidence-based health solutions, contributing to the broader nutraceutical market with products that prioritize efficacy and bioavailability.
